Federal Judge Dismisses Texas Kickback Indictment Involving 10 Doctors, Pharma Executives
A Texas federal judge tossed a superseding indictment accusing 10 doctors, two pharmaceutical executives and two business entities of a kickback scheme involving prescriptions that spanned six years from 2013 to 2019.
The defendants had moved to dismiss the superseding indictment on several grounds, including statute-of-limitations issues.
Rather than respond to that motion, the prosecutors moved to dismiss the case “in the interests of justice.”

